Maurizio Mascarin Selected Research

Maurizio Mascarin Research Topics

20	Hodgkin Disease (Hodgkin's Disease) 12/2023 - 01/2016
12	Neoplasms (Cancer) 10/2023 - 04/2004
5	Medulloblastoma 08/2022 - 03/2010
3	Sarcoma (Soft Tissue Sarcoma) 10/2023 - 06/2021
3	Infections 02/2023 - 02/2022
3	COVID-19 02/2023 - 07/2020
3	Ependymoma 12/2022 - 07/2011
2	Lymphoma (Lymphomas) 03/2022 - 01/2013
2	Necrosis 01/2022 - 06/2021
2	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 11/2014
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2021 - 01/2013
2	Neoplasm Metastasis (Metastasis) 06/2021 - 04/2004
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 01/2013
2	Primitive Neuroectodermal Tumors (PNET) 05/2014 - 03/2010
2	Familial ependymoma 08/2006 - 04/2004
1	Cardiotoxicity 10/2023
1	Hand-Foot Syndrome 10/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 06/2021
1	Sclerosis 05/2021
1	Left Ventricular Dysfunction 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Wilms Tumor (Wilm's Tumor) 12/2019
1	Rhabdomyosarcoma 12/2019
1	Inflammation (Inflammations) 01/2018
1	Central Nervous System Neoplasms 01/2018
1	Pathologic Complete Response 01/2015
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Nasopharyngeal Carcinoma 09/2011
1	Residual Neoplasm 07/2011

7	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2018
3	Ifosfamide FDA LinkGeneric 10/2023 - 11/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 11/2014
2	Brentuximab VedotinIBA 01/2023 - 10/2022
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 01/2013
2	Cell-Free Nucleic AcidsIBA 01/2016 - 01/2013
2	Temozolomide (Temodar)FDA LinkGeneric 05/2014 - 03/2010
1	OsteopontinIBA 12/2023
1	1-dodecylpyridoxal (PLD)IBA 10/2023
1	liposomal doxorubicin (Doxil)FDA Link 10/2023
1	Antineoplastic Agents (Antineoplastics)IBA 10/2023
1	Bendamustine Hydrochloride FDA Link 01/2023
1	NivolumabIBA 01/2023
1	COVID-19 VaccinesIBA 02/2022
1	VaccinesIBA 02/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	mifamurtideIBA 01/2022
1	Rituximab (Mabthera)FDA Link 11/2021
1	Melphalan (Alkeran)FDA LinkGeneric 06/2021
1	Busulfan (Busulfex)FDA Link 06/2021
1	AnthracyclinesIBA 01/2021
1	Janus KinasesIBA 10/2019
1	Immune Checkpoint InhibitorsIBA 10/2019
1	LigandsIBA 10/2019
1	Fluorine-18IBA 01/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2017
1	HLA-G Antigens (HLA G)IBA 12/2017
1	Cisplatin (Platino)FDA LinkGeneric 11/2014
1	Methotrexate (Mexate)FDA LinkGeneric 11/2014
1	Cytidine Diphosphate (CDP)IBA 11/2014
1	Anaplastic Lymphoma KinaseIBA 01/2013

13	Drug Therapy (Chemotherapy) 08/2022 - 04/2004
12	Radiotherapy 01/2023 - 04/2004
8	Therapeutics 02/2023 - 12/2019
5	Salvage Therapy 12/2022 - 08/2006
2	Neoadjuvant Therapy 06/2021 - 09/2011
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 09/2011 - 03/2010
1	Music Therapy 02/2023
1	Cell Transplantation 01/2023
1	Adjuvant Radiotherapy 08/2022
1	Adjuvant Chemotherapy 08/2022
1	Contraindications 02/2022
1	Treatment Delay 02/2022
1	Stem Cell Transplantation 06/2021
1	Phototherapy (Light Therapy) 01/2020
1	Ligation 10/2019
1	Combined Modality Therapy 01/2015
1	Induction Chemotherapy 09/2011
1	Craniospinal Irradiation 03/2010